BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23494240)

  • 1. Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma.
    Dong Y; Zhuang L; Ma W
    Tumour Biol; 2013 Apr; 34(2):1155-60. PubMed ID: 23494240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk.
    Zhou L; Lu Y; Yang G; Wu J
    Tumour Biol; 2014 Feb; 35(2):1427-32. PubMed ID: 24277375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
    Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
    Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies.
    Zhu HL; Bao JM; Lin PX; Li WX; Zou ZN; Huang YE; Chen Q; Shen H
    Asian Pac J Cancer Prev; 2014; 15(16):6619-25. PubMed ID: 25169498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
    Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
    World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of excision repair cross-complementing group 2 gene Lys751Gln and Asp312Asn polymorphisms in melanoma risk.
    Zhou X; Zeng Y; Jiang H; Xia L; Liu C
    Melanoma Res; 2018 Aug; 28(4):311-318. PubMed ID: 29768284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.
    Wu KG; He XF; Li YH; Xie WB; Huang X
    Tumour Biol; 2014 Nov; 35(11):11243-59. PubMed ID: 25113251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.
    Ding DP; Ma WL; He XF; Zhang Y
    Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians.
    Zhang J; Gu SY; Zhang P; Jia Z; Chang JH
    Eur J Cancer; 2010 Sep; 46(13):2479-84. PubMed ID: 20627704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility.
    Wen F; Zhao Z; Liu C; Yin Q; Weng J; Wang Y; Ma Y
    Tumour Biol; 2014 Apr; 35(4):2959-65. PubMed ID: 24234258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
    Xin Y; Hao S; Lu J; Wang Q; Zhang L
    PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls.
    Yuan L; Cui D; Zhao EJ; Jia CZ; Wang LD; Lu WQ
    World J Gastroenterol; 2011 May; 17(18):2343-8. PubMed ID: 21633601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.
    Du H; Guo N; Shi B; Zhang Q; Chen Z; Lu K; Shu Y; Chen T; Zhu L
    PLoS One; 2014; 9(5):e96301. PubMed ID: 24787743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.
    Wu Y; Yang Y
    Tumour Biol; 2014 Jun; 35(6):5245-57. PubMed ID: 24504678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
    Yuan H; Niu YM; Wang RX; Li HZ; Chen N
    Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
    Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
    Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.
    Zhang RC; Mou SH
    Tumour Biol; 2013 Apr; 34(2):901-7. PubMed ID: 23271362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
    Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
    Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.
    Guo XF; Wang J; Lei XF; Zeng YP; Dong WG
    Intern Med; 2015; 54(3):251-9. PubMed ID: 25748732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
    Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X
    Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.